Lungs News and Research

RSS

New treatment approach for severe asthma

Researchers have uncovered a potentially new treatment approach for severe asthma, by blocking a powerful immune system chemical, present in large amounts in patients with the severe form of the disease, a small study in Thorax reveals.

20 Sep 2005

Researchers identify gene prevalent in the population that controls the clinical severity of asthma

The study by Bucala and his colleagues in Dublin, Ireland, included experiments in mice that are resistant to developing asthma because they lack the gene, and an examination of a human population in Dublin chosen for their similar ethnic and geographic identity.

20 Sep 2005

Research could improve clinical care, help educate women on premature birth

A March of Dimes expert panel has recommended a targeted research agenda designed improve the lives of thousands of babies by preventing premature birth. The agenda has been published in the American Journal of Obstetrics and Gynecology.

20 Sep 2005

Study points to importance of MYC gene in cancer progression

The cancer gene MYC is among the most commonly overexpressed oncogenes in human cancers. Most human cancers demonstrate high levels of MYC or its biological partners, including those of the breast, ovaries, lung, prostate, and skin, as well as leukemias and lymphomas.

19 Sep 2005

Compounds found in broccoli, cauliflower, and watercress block lung cancer progression

A family of compounds found in cruciferous vegetables, such as broccoli, cauliflower, and watercress, blocked lung cancer progression in both animal studies and in tests with human lung cancer cells, report researchers from Georgetown University Medical Center and the Institute for Cancer Prevention.

19 Sep 2005

Tarceva should be tested as front-line therapy for older lung cancer patients

The tyrosine kinase inhibitor erlotinib (Tarceva) showed encouraging activity with relatively tolerable side effects in elderly, previously untreated patients with advanced non-small cell lung cancer (NSCLC), reports a team led by investigators from Dana-Farber Cancer Institute in Boston.

19 Sep 2005

Scientists have discovered a new and potent anti-cancer compound in beans

Scientists have discovered a new and potent anti-cancer compound in everyday food. The collaborative study led by UCL (University College London) shows that the compound - inositol pentakisphosphate - found in beans, nuts and cereals inhibits a key enzyme (phosphoinositide 3-kinase) involved in tumour growth.

19 Sep 2005

Molecular pathway in mice that makes prostate cells vulnerable to cancer-causing oxygen damage

Scientists from Maryland and New Jersey have identified a molecular pathway in mice that makes prostate cells vulnerable to cancer-causing oxygen damage.

19 Sep 2005

Lowering blood sugar levels could reduce the risk of coronary heart disease

Lowering blood sugar levels could reduce the risk of coronary heart disease in both diabetics and non-diabetics, according to researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions.

19 Sep 2005

RNAi therapeutic successful for treatment of SARS respiratory virus in Rhesus Macaque

Intradigm Corporation announced today its collaboration with Chinese academic and biotech groups has achieved clear evidence of prophylactic and therapeutic effects of siRNA (small interfering RNA) agents in Rhesus monkey to treat SARS coronavirus (SCV) respiratory infection.

12 Sep 2005

Transplantation of organs from animals to humans could soon be a reality

Speaking at the BA Festival of Science in Dublin, Dr Anthony Warrens, discussed how xenotransplantation, the process of transplanting organs from one species into another, could soon be a reality, easing the current shortage of organs for transplantation.

10 Sep 2005

Inhaled-insulin drug Exubera - monitoring programme to be launched by Pfizer

Drug company Pfizer says it is all set to launch a patient-monitoring scheme in order to assess the safety of its novel inhaled-insulin drug Exubera, if the product is approved for use.

10 Sep 2005

Smokers twice as likely to lose their sight - calls for warnings on cigarette packets

Experts are warning smokers that they are twice as likely as non-smokers to lose their sight in later life.

10 Sep 2005

Call for more donations of brains to help researchers discover new treatments for neurological disorders

Speaking at the BA Festival of Science, at Trinity College, Dublin, Dr Kirstin Goldring from Imperial College London and Charing Cross Hospital is calling for more donations of brains to help researchers discover new treatments for neurological disorders.

7 Sep 2005

Researchers uncover how the inhaled form of anthrax disarms bacteria-fighting white blood cells before they can fend off the disease

The lethal toxin in anthrax paralyzes neutrophils, the white blood cells that act as the body's first defense against infection, by impairing how they build tiny filaments that allow them to crawl throughout the body and eat invading bacteria.

6 Sep 2005

Killer secondhand smoke campaign flares up in the UK

According to new research by the National Health Service (NHS), 60 per cent of smokers light up and smoke without asking for permission, despite the fact that most non-smokers mind if other people are smoking nearby.

6 Sep 2005

Exposure to secondhand smoke kills as many women in China as does smoking

The study estimated that in 2002, 48,400 women in China died from lung cancer and ischemic heart disease attributed to passive smoking compared with 47,300 lung cancer and heart disease deaths from "active" smoking.

6 Sep 2005

Osteopontin protein found to be more common in patients with lung fibrosis

Idiopathic pulmonary fibrosis (IPF) is a scarring disease without a cure, irreparably damaging the ability of the tissue to transfer oxygen into the bloodstream.

6 Sep 2005

Health groups file brief urging tougher remedies in tobacco lawsuit

The six public health organizations that intervened in the federal government's tobacco lawsuit filed a brief last Wednesday urging the judge to strengthen the remedies proposed by the government

6 Sep 2005

Amnioinfusion does not reduce the risk of meconium aspiration syndrome

An international randomized trial, funded by the Canadian Institutes of Health Research (CIHR), has revealed that amnioinfusion, the infusion of saline into the uterus, does not reduce the risk of meconium aspiration syndrome (MAS), as previously believed.

6 Sep 2005